Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
G protein-coupled receptors
Biotech
Septerna goes public with upsized offering of $288M
Septerna has scored with an upsized IPO of $288M, which exceeded the $157.9M the company said it expected to generate early this week.
Kevin Dunleavy
Oct 25, 2024 10:29am
Septerna plans $158M IPO to fund readouts for GPCR pipeline
Oct 21, 2024 8:30am
Lilly-backed Superluminal speeds toward the clinic with $120M
Sep 9, 2024 7:00am
AbbVie buys antibody-focused biotech DJS for $255M
Oct 20, 2022 12:40pm
Former Janssen US oncology chief to lead Teon Therapeutics
Mar 8, 2022 5:30am
Septerna launches with $100M and GPCR pioneer co-founder
Jan 27, 2022 7:00am
